Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cluster headache
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Verapamil=== The recommended first-line preventive therapy is [[verapamil]], a [[calcium channel blocker]].<ref name=AFP2013/><ref name=EFNS>{{cite journal |doi=10.1111/j.1468-1331.2006.01566.x |pmid=16987158 |title=EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias |journal=European Journal of Neurology |volume=13 |issue=10 |pages=1066–77 |year=2006 |last1=May |first1=A. |last2=Leone |first2=M. |last3=Áfra |first3=J. |last4=Linde |first4=M. |last5=Sándor |first5=P. S. |last6=Evers |first6=S. |last7=Goadsby |first7=P. J. |doi-access=free }}</ref> Verapamil was previously underused in people with cluster headache.<ref name=Beck/> Improvement can be seen in an average of 1.7 weeks for episodic cluster headache and 5 weeks for chronic cluster headache when using a dosage of ranged between 160 and 720 mg (mean 240 mg/day).<ref name="vera">{{cite journal |vauthors=Petersen AS, Barloese MC, Snoer A, Soerensen AM, Jensen RH | title =Verapamil and Cluster Headache: Still a Mystery. A Narrative Review of Efficacy, Mechanisms and Perspectives | journal =Headache| date = 2019 | volume =59| issue =8| pages =1198–1211| pmid = 31339562| doi = 10.1111/head.13603| s2cid =198193843 }}</ref> Preventive therapy with verapamil is believed to work because it has an effect on the circadian rhythm and on CGRPs as CGRP-release is controlled by voltage-gated calcium channels.<ref name="vera"/>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)